Resources

Past Presentation

Common HCV DAA Drug Interactions | September 27, 2023

Date of Presentation: September 27, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #drug interactions  #hcv  #hcv monitoring  #hcv treatment  #hep c  #hepatitis  #medications  

In this presentation, Dr. Paulina Deming describes the interaction potential between DAA therapies and common medications, and identifies when DAA therapies and diabetic medications are most likely to result in hypoglycemia.

 

Recording:

Presented by:

Dr. Paulina Deming, PharmD

Dr. Paulina Deming, PharmD, is an Associate Professor-Clinical Educator within the Pharmacy Practice and Administrative Sciences Department at the College of Pharmacy at the University of New Mexico Health Sciences Center (UNMHSC). Dr. Deming completed a general practice residency and infectious diseases pharmacotherapy residency at UNMHSC. Her interests are focused in hepatitis C virus (HCV) infections and clinical therapeutics. She is the assistant director for the Project ECHO (Extension for Community Healthcare Outcomes) HCV clinic and serves on Project ECHO’s expert faculty panel advising providers on HCV care in community, corrections, and within the Indian Health Services settings. Licensed as a pharmacist clinician, she sees patients through the UNMHSC’s HCV clinic and the Truman HCV-HIV coinfection clinic. In addition to teaching and clinical work, Dr. Deming has co-authored papers on the management of HCV infections as well as HCV treatment outcomes in real-world settings.

Resources Provided:

Date added: September 25, 2023